201 related articles for article (PubMed ID: 20682686)
1. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract][Full Text] [Related]
2. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-apoptotic Bcl-2 homology domain-3-only protein BMF.
Kilbride SM; Farrelly AM; Bonner C; Ward MW; Nyhan KC; Concannon CG; Wollheim CB; Byrne MM; Prehn JH
J Biol Chem; 2010 Nov; 285(46):36199-206. PubMed ID: 20841353
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of pancreatic stone protein (PSP)/reg1A as an indicator of beta-cell apoptosis suggest an increased apoptosis rate in hepatocyte nuclear factor 1 alpha (HNF1A-MODY) carriers from the third decade of life onward.
Bacon S; Kyithar MP; Schmid J; Rizvi SR; Bonner C; Graf R; Prehn JH; Byrne MM
BMC Endocr Disord; 2012 Jul; 12():13. PubMed ID: 22808921
[TBL] [Abstract][Full Text] [Related]
7. Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.
Farrelly AM; Wobser H; Bonner C; Anguissola S; Rehm M; Concannon CG; Prehn JH; Byrne MM
Diabetologia; 2009 Jan; 52(1):136-44. PubMed ID: 18949455
[TBL] [Abstract][Full Text] [Related]
8. Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death.
Wobser H; Düssmann H; Kögel D; Wang H; Reimertz C; Wollheim CB; Byrne MM; Prehn JH
J Biol Chem; 2002 Feb; 277(8):6413-21. PubMed ID: 11724785
[TBL] [Abstract][Full Text] [Related]
9. Identification of circulating microRNAs in HNF1A-MODY carriers.
Bonner C; Nyhan KC; Bacon S; Kyithar MP; Schmid J; Concannon CG; Bray IM; Stallings RL; Prehn JH; Byrne MM
Diabetologia; 2013 Aug; 56(8):1743-51. PubMed ID: 23674172
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of protein kinase B/Akt-1 mediates INS-1 insulinoma cell apoptosis induced by dominant-negative suppression of hepatocyte nuclear factor-1alpha function.
Wobser H; Bonner C; Nolan JJ; Byrne MM; Prehn JH
Diabetologia; 2006 Mar; 49(3):519-26. PubMed ID: 16440211
[TBL] [Abstract][Full Text] [Related]
11. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
[TBL] [Abstract][Full Text] [Related]
12. Defective functions of HNF1A variants on BCL2L1 transactivation and beta-cell growth.
Sujjitjoon J; Charoensuk C; Thanyaphon T; Kooptiwut S; Thamtarana PJ; Tangjittipokin W; Chongjaroen N; Chanprasert C; Abubakar Z; Lapbenjakul S; Yenchitsomanus PT; Plengvidhya N
Biochem Biophys Res Commun; 2020 Aug; 529(3):826-833. PubMed ID: 32684311
[TBL] [Abstract][Full Text] [Related]
13. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic stone protein/regenerating protein (PSP/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus.
Yang J; Li L; Raptis D; Li X; Li F; Chen B; He J; Graf R; Sun Z
Endocrine; 2015 Apr; 48(3):856-62. PubMed ID: 25234740
[TBL] [Abstract][Full Text] [Related]
15. Co-inheritance of HNF1a and GCK mutations in a family with maturity-onset diabetes of the young (MODY): implications for genetic testing.
López-Garrido MP; Herranz-Antolín S; Alija-Merillas MJ; Giralt P; Escribano J
Clin Endocrinol (Oxf); 2013 Sep; 79(3):342-7. PubMed ID: 23009393
[TBL] [Abstract][Full Text] [Related]
16. Half-Life of Sulfonylureas in HNF1A and HNF4A Human MODY Patients is not Prolonged as Suggested by the Mouse Hnf1a(-/-) Model.
Urbanova J; Andel M; Potockova J; Klima J; Macek J; Ptacek P; Mat'oska V; Kumstyrova T; Heneberg P
Curr Pharm Des; 2015; 21(39):5736-48. PubMed ID: 26446475
[TBL] [Abstract][Full Text] [Related]
17. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
Mughal SA; Park R; Nowak N; Gloyn AL; Karpe F; Matile H; Malecki MT; McCarthy MI; Stoffel M; Owen KR
Diabet Med; 2013 Feb; 30(2):246-50. PubMed ID: 23157689
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of p.Pro409His variant in HNF1A, a hypomorphic mutation involved in pancreatic β-cell dysfunction.
Nocera D; Menniti M; Belviso S; Bond HM; Lanzillotta D; Spoleti CB; Guagliardi MR; Malatesta P; Trapasso F; Irace C; Perrotti N; Iuliano R
Acta Diabetol; 2019 Aug; 56(8):883-888. PubMed ID: 30963309
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of HNF1A gene mutations in patients with MODY 3 phenotype and identification of three novel germline mutations in Turkish Population.
Karaca E; Onay H; Cetinkalp S; Aykut A; Göksen D; Ozen S; Atik T; Darcan S; Tekin IM; Ozkınay F
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S491-S496. PubMed ID: 28395978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
